Literature DB >> 12529383

Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment.

Mario Maira1, Christine Martens, Eric Batsché, Yves Gauthier, Jacques Drouin.   

Abstract

The NGFI-B (Nur77) subfamily of orphan nuclear receptors (NRs), which also includes Nurr1 and NOR1, bind the NurRE regulatory element as either homo- or heterodimers formed between subfamily members. These NRs mediate the activation of pituitary proopiomelanocortin (POMC) gene transcription by the hypothalamic hormone corticotropin-releasing hormone (CRH), an important link between neuronal and endocrine components of the hypothalamo-pituitary-adrenal axis. CRH effects on POMC transcription do not require de novo protein synthesis. We now show that CRH signals activate Nur factors through the cyclic AMP/protein kinase A (PKA) pathway. CRH and PKA rapidly increase nuclear DNA binding activity of NGFI-B dimers but not monomers. Accordingly, CRH- or PKA-activated Nur factors enhance dimer (but not monomer) target response elements. We also show that p160/SRC coactivators are recruited to Nur dimers (but not to monomers) and that coactivator recruitment to the NurRE is enhanced in response to CRH. Moreover, PKA- and coactivator-induced potentiation of NGFI-B activity are primarily exerted through the N-terminal AF-1 domain of NGFI-B. The TIF2 (SRC-2) glutamine-rich domain is required for this activity. Taken together, these results indicate that Nur factors behave as endpoint effectors of the PKA signaling pathway acting through dimers and AF-1-dependent recruitment of coactivators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529383      PMCID: PMC140697          DOI: 10.1128/MCB.23.3.763-776.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  91 in total

1.  Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation.

Authors:  Y Li; L F Lau
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1.

Authors:  P A Crawford; J A Polish; G Ganpule; Y Sadovsky
Journal:  Mol Endocrinol       Date:  1997-10

3.  Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Authors:  A Philips; M Maira; A Mullick; M Chamberland; S Lesage; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Nur77 is differentially modified in PC12 cells upon membrane depolarization and growth factor treatment.

Authors:  T G Hazel; R Misra; I J Davis; M E Greenberg; L F Lau
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

6.  Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1.

Authors:  M Ito; R N Yu; J L Jameson
Journal:  Mol Endocrinol       Date:  1998-02

7.  Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements.

Authors:  M Therrien; J Drouin
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

8.  Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor.

Authors:  Y Katagiri; Y Hirata; J Milbrandt; G Guroff
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

9.  Expression of the nerve growth factor-regulated NGFI-A and NGFI-B genes in the developing rat.

Authors:  M A Watson; J Milbrandt
Journal:  Development       Date:  1990-09       Impact factor: 6.868

10.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

Authors:  K Umesono; K K Murakami; C C Thompson; R M Evans
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

View more
  51 in total

1.  FHL2 protein is a novel co-repressor of nuclear receptor Nur77.

Authors:  Kondababu Kurakula; Erik van der Wal; Dirk Geerts; Claudia M van Tiel; Carlie J M de Vries
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

2.  Anti-steroidogenic factor ARR19 inhibits testicular steroidogenesis through the suppression of Nur77 transactivation.

Authors:  Imteyaz Qamar; Eun-Yeung Gong; Yeawon Kim; Chin-Hee Song; Hyun Joo Lee; Sang-Young Chun; Keesook Lee
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

Review 3.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

Review 4.  The role of NR4A transcription factors in memory formation.

Authors:  Josh D Hawk; Ted Abel
Journal:  Brain Res Bull       Date:  2011-02-18       Impact factor: 4.077

5.  Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by α7 nicotinic receptor agonist.

Authors:  Sridhar T Narla; Ilona Klejbor; Barbara Birkaya; Yu-Wei Lee; Janusz Morys; Ewa K Stachowiak; Dorota Prokop; Merouane Bencherif; Michal K Stachowiak
Journal:  Stem Cells Transl Med       Date:  2013-09-06       Impact factor: 6.940

Review 6.  Targeting NR4A1 (TR3) in cancer cells and tumors.

Authors:  Syng-Ook Lee; Xi Li; Shaheen Khan; Stephen Safe
Journal:  Expert Opin Ther Targets       Date:  2011-01-05       Impact factor: 6.902

7.  Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

Authors:  Steve Bilodeau; Sophie Vallette-Kasic; Yves Gauthier; Dominique Figarella-Branger; Thierry Brue; France Berthelet; André Lacroix; Dalia Batista; Constantine Stratakis; Jeanette Hanson; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

8.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Authors:  Pierre-Luc Lavoie; Lionel Budry; Aurélio Balsalobre; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2008-04-03

9.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

10.  Role for TGF-beta superfamily signaling in telencephalic GABAergic neuron development.

Authors:  Mario Maira; Jason E Long; Amie Y Lee; John L R Rubenstein; Stefano Stifani
Journal:  J Neurodev Disord       Date:  2009-11-27       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.